Levocarnitine for pegaspargase‐induced hepatotoxicity in older children and young adults with acute lymphoblastic leukemia
Published 2021 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Levocarnitine for pegaspargase‐induced hepatotoxicity in older children and young adults with acute lymphoblastic leukemia
Authors
Keywords
-
Journal
Cancer Medicine
Volume -, Issue -, Pages -
Publisher
Wiley
Online
2021-09-16
DOI
10.1002/cam4.4281
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Comparison of CALGB 10403 (Alliance) and COG AALL0232 toxicity results in young adults with acute lymphoblastic leukemia
- (2021) Anjali S. Advani et al. Blood Advances
- Prevalence, characteristics and mortality outcomes of obese, nonobese and lean NAFLD in the United States, 1999–2016
- (2020) B. Zou et al. JOURNAL OF INTERNAL MEDICINE
- A pediatric regimen for older adolescents and young adults with acute lymphoblastic leukemia: results of CALGB 10403
- (2019) Wendy Stock et al. BLOOD
- L-carnitine does not ameliorate asparaginase-associated hepatotoxicity in a C57BL6 mouse model
- (2019) Yiwei Liu et al. LEUKEMIA & LYMPHOMA
- Levocarnitine does not impair chemotherapy cytotoxicity against acute lymphoblastic leukemia
- (2019) Jessica L. Sea et al. LEUKEMIA & LYMPHOMA
- Efficacy and toxicity of reduced vs. standard dose pegylated asparaginase in adults with Philadelphia chromosome-negative acute lymphoblastic leukemia
- (2019) Benjamin A. Derman et al. LEUKEMIA & LYMPHOMA
- Incidence and predictors of treatment‐related conjugated hyperbilirubinemia during early treatment phases for children with acute lymphoblastic leukemia
- (2019) Saman K. Hashmi et al. PEDIATRIC BLOOD & CANCER
- L-carnitine and Vitamin B Complex for the Treatment of Pegasparaginase-induced Hyperbilirubinemia
- (2018) Caitlin R. Rausch et al. Clinical Lymphoma Myeloma & Leukemia
- Levocarnitine for asparaginase-induced hepatic injury: a multi-institutional case series and review of the literature
- (2018) Rachael R. Schulte et al. LEUKEMIA & LYMPHOMA
- Pegaspargase-related high-grade hepatotoxicity in a pediatric-inspired adult acute lymphoblastic leukemia regimen does not predict recurrent hepatotoxicity with subsequent doses
- (2018) Patrick W. Burke et al. LEUKEMIA RESEARCH
- Obesity challenges the hepatoprotective function of the integrated stress response to asparaginase exposure in mice
- (2017) Inna A. Nikonorova et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- PEGging down risk factors for peg-asparaginase hepatotoxicity in patients with acute lymphoblastic leukemia
- (2017) Caitlin R. Rausch et al. LEUKEMIA & LYMPHOMA
- Predictors of hepatotoxicity and pancreatitis in children and adolescents with acute lymphoblastic leukemia treated according to contemporary regimens
- (2017) Christopher C. Denton et al. PEDIATRIC BLOOD & CANCER
- Incidence of asparaginase-related hepatotoxicity, pancreatitis, and thrombotic events in adults with acute lymphoblastic leukemia treated with a pediatric-inspired regimen
- (2017) Trevor N Christ et al. JOURNAL OF ONCOLOGY PHARMACY PRACTICE
- Levocarnitine and vitamin B complex for the treatment of pegaspargase-induced hepatotoxicity: A case report and review of the literature
- (2017) Alison Blackman et al. JOURNAL OF ONCOLOGY PHARMACY PRACTICE
- L-Carnitine for Treatment of Pegasparaginase-Induced Hepatotoxicity
- (2016) Ruham Alshiekh-Nasany et al. ACTA HAEMATOLOGICA
- Pegylated-asparaginase during induction therapy for adult acute lymphoblastic leukaemia: toxicity data from the UKALL14 trial
- (2016) B Patel et al. LEUKEMIA
- Prognostic significance of minimal residual disease in high risk B-ALL: a report from Children's Oncology Group study AALL0232
- (2015) M. J. Borowitz et al. BLOOD
- Toxicity profile of repeated doses of PEG-asparaginase incorporated into a pediatric-type regimen for adult acute lymphoblastic leukemia
- (2015) Ibrahim Aldoss et al. EUROPEAN JOURNAL OF HAEMATOLOGY
- Long-term outcome of a pediatric-inspired regimen used for adults aged 18–50 years with newly diagnosed acute lymphoblastic leukemia
- (2014) D J DeAngelo et al. LEUKEMIA
- A Primer on Marginal Effects—Part I: Theory and Formulae
- (2014) Eberechukwu Onukwugha et al. PHARMACOECONOMICS
- L-Carnitine Ameliorates L-Asparaginase-Induced Acute Liver Toxicity in Steatotic Rat Livers
- (2013) Anne Roesmann et al. CHEMOTHERAPY
- Successful treatment ofl-asparaginase-induced severe acute hepatotoxicity using mitochondrial cofactors
- (2013) Chadi Al-Nawakil et al. LEUKEMIA & LYMPHOMA
- Racial differences in nonalcoholic fatty liver disease in the U.S. population
- (2013) Andrea L. C. Schneider et al. Obesity
- Increasing Prevalence of Nonalcoholic Fatty Liver Disease Among United States Adolescents, 1988-1994 to 2007-2010
- (2012) Jean A. Welsh et al. JOURNAL OF PEDIATRICS
- Prevention and management of asparaginase/pegasparaginase-associated toxicities in adults and older adolescents: recommendations of an expert panel
- (2011) Wendy Stock et al. LEUKEMIA & LYMPHOMA
- L-Carnitine for Acute Valproic Acid Overdose: A Systematic Review of Published Cases
- (2010) Jerrold Perrott et al. ANNALS OF PHARMACOTHERAPY
- Tolerability and Efficacy of L-Asparaginase Therapy in Pediatric Patients With Acute Lymphoblastic Leukemia
- (2010) Elizabeth A. Raetz et al. JOURNAL OF PEDIATRIC HEMATOLOGY ONCOLOGY
Add your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload NowBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started